Breadcrumb Home News Minnesota dials back COVID-19 antibody strategy as omicron tops 50% of new cases Minnesota dials back COVID-19 antibody strategy as omicron tops 50% of new cases December 22, 2021 JP Leider, PhD comments on access during the Omicron surge. Previous News Christopher Wong Michaelson, PhD, Has Been Named the Koch Endowed Chair for Business Ethics at the University of St. Thomas Daniel Groll, PhD, Has Been Selected As One of the Mellon Periclean Faculty Leaders in the Humanities Rachel R. Hardeman, PhD, MPH, Joins the Hastings Center Board of Directors
